W738 (Alfuzosin hydrochloride extended-release 10 mg)
Pill imprint W738 has been identified as Alfuzosin hydrochloride extended-release 10 mg.
Alfuzosin is used in the treatment of benign prostatic hyperplasia and belongs to the drug class antiadrenergic agents, peripherally acting. There is no proven risk in humans during pregnancy. Alfuzosin 10 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for W738 (Alfuzosin hydrochloride extended-release 10 mg)
More about alfuzosin
- Other brands: Uroxatral
Compare with other treatments for:
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...